تداخل‌های دارویی
Ciltacabtagene autoleucel + Pemetrexed
شدت: شدید
Ciltacabtagene autoleucel and Pemetrexed: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Pemetrexed is a myelosuppressive antimetabolite that can impair the expansion and function of CAR T cells and increase infection risk. Chemotherapy around the time of CAR T infusion can reduce the efficacy of the cell product and worsen cytopenias.
معنای این تداخل به زبان ساده
Ciltacabtagene autoleucel and Pemetrexed can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Ciltacabtagene autoleucel belongs to Miscellaneous; Pemetrexed belongs to Oncology.
چرا رخ می‌دهد
Cytotoxic and myelosuppressive effects of pemetrexed may reduce CAR T-cell persistence and add to immunosuppression.
اقدام لازم
Avoid giving pemetrexed around leukapheresis and during the period after CAR T infusion unless clearly needed. Monitor blood counts and screen for infection.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Ciltacabtagene autoleucel و Pemetrexed، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۷ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Pemetrexed
تداخلات دیگر Ciltacabtagene autoleucel
پرسش‌های متداول
Can I take Ciltacabtagene autoleucel with Pemetrexed?
MediHelp rates the interaction as major. Ciltacabtagene autoleucel and Pemetrexed can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pemetrexed is a myelosuppressive antimetabolite that can impair the expansion and function of CAR T cells and increase infection risk. Chemotherapy around the time of CAR T infusion can reduce the efficacy of the cell product and worsen cytopenias.
How serious is the interaction between Ciltacabtagene autoleucel and Pemetrexed?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid giving pemetrexed around leukapheresis and during the period after CAR T infusion unless clearly needed. Monitor blood counts and screen for infection.
What other medicines interact with Pemetrexed?
MediHelp also lists interactions of Pemetrexed with, for example, Bacitracin, Brexucabtagene autoleucel, Celecoxib. The full list is on the Pemetrexed page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
